John Loper
Saturday, April 28, 2018
Apr 27, 2018 This Week in Cardiology
›
Lipid-lowering and baseline LDL-C, the CV safety of NSAIDs, 'metabolically healthy' obesity, PCI for chronic total occlusions, and w...
After Stroke, Delaying SAVR Cuts Risk for New Stroke
›
The recurrent-stroke risk truly spikes at surgical aortic valve replacement within 3 months of a prior stroke, say researchers of a cohort s...
Friday, April 27, 2018
Tenecteplase: Thrombolytic of Choice in Stroke?
›
The EXTEND-IA TNK trial suggesting better outcomes with tenecteplase than alteplase in the treatment of acute ischemic stroke has now been p...
Pets, the not-so-secret weapon to help patients recover from what ails them
›
By AMERICAN HEART ASSOCIATION NEWS When Scott Vande Zande had a serious stroke 15 years ago, his beloved golden retriever Hollie was key to ...
PROGRESS CTO: PCI Successful in Nearly 9 of 10 CTOs
›
The results may provide important benchmarking for discussion about the risk:benefit ratio of the procedure, which has been called the last ...
How black cardiologists are combating a heart problem affecting millions
›
By AMERICAN HEART ASSOCIATION NEWS Doctors and African-American communities are obligated to learn more about heart valve disease and the li...
CV Safety of Celecoxib Similar to Naproxen, Ibuprofen, FDA Panels Say
›
Two FDA panels jointly voted by a large margin that the cardiovascular safety of celecoxib is comparable to naproxen and ibuprofen.
›
Home
View web version